New antibody therapy shows promising results for advanced, treatment-refractory pediatric brain cancer
Effective and safe treatments are needed for medulloblastoma—the most common type of cancerous brain tumor in children—especially for patients whose cancer has spread to the spinal cord. A recent phase I clinical trial led by researchers at Atrium Health Levine…
A Closer Look at Glioblastoma and New Reasons for Hope
Approximately 15,000 Americans will be diagnosed with glioblastoma this year. Although considered a rare cancer, doctors are seeing an increase in cases of the aggressive and deadly brain cancer that’s notoriously hard to treat. A local organization that’s helping enroll…
After Nearly 4 Decades of Research, W.K. Alfred Yung, MD, Sees a New Era Ahead for Advances in Brain Tumors
After he was not accepted into the University of Hong Kong, plan B for W.K. Alfred Yung, MD, was to leave his country and immigrate to the United States to attend the University of Minnesota in Minneapolis—a move he considers…
Using rooom to Build a Community
Together with the National Foundation for Cancer Research (NFCR) and the AIM-HI Accelerator Fund (AIM-HI) we hosted a charitable hybrid combo event on October 30 2021 – our first big project in the United States. While the live event took place at…
Cancer Drug Design Company Associated with Longtime NFCR Support Attracts New Investment
Rasio Therapeutics, a company whose cancer drug research technology was developed and applied in part with funding provided over many years by the National Foundation for Cancer Research to University of Maryland, Baltimore, researcher Curt Civin, has raised additional investment…
Strategic Media Partner
